Home › Stocks › JNJ vs PFE
JNJ
Johnson & Johnson
$238.49
vs
PFE
Pfizer Inc.
$25.60

Head-to-Head Comparison

MetricJNJPFE
Market Cap$574.1B$145.9B
P/E Ratio16.010.0
Div YieldN/AN/A
SectorHealthcareHealthcare
Beta0.260.29
RevenueN/AN/A
Net IncomeN/AN/A
EPSN/AN/A

AI Comparison Brief

AI Generated
Verdict
Johnson & Johnson (JNJ) is the better investment compared to Pfizer Inc. (PFE) due to its superior market capitalization of $574.10 billion versus PFE's $145.91 billion, indicating a stronger market position and stability. JNJ's beta of 0.256 suggests lower volatility and risk, appealing to conservative investors. While both companies share a similar industry, JNJ's broader product range and established reputation provide a more attractive growth trajectory.
Key Differences
  • Market Capitalization: JNJ's market cap of $574.10 billion significantly outweighs PFE's $145.91 billion, reflecting a more robust presence in the healthcare sector.
  • Risk Profile: JNJ's lower beta (0.256) indicates it is less volatile compared to PFE's beta of 0.295, appealing to risk-averse investors.
  • Business Model: JNJ operates with a diversified portfolio across consumer health, pharmaceuticals, and medical devices, while PFE primarily focuses on pharmaceuticals, which may expose it to greater industry-specific risks.
  • Dividend Consideration: Although both companies show N/A for dividend yield, JNJ's historical commitment to dividends may provide a more stable income in the long term compared to PFE.
Bottom Line
For investors prioritizing stability and market strength, JNJ is the preferable choice, while those seeking potential growth in pharmaceuticals may consider PFE. However, overall, JNJ offers a more secure investment in the healthcare sector.
This comparison is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Analysis generated 2026-06-16

Price Chart — JNJ vs PFE

Loading chart...
→ Johnson & Johnson (JNJ) Full Analysis → Pfizer Inc. (PFE) Full Analysis ← Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms